http://www.unboundmedicine.com/medline/ebm/research/erlotinibUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19892771/full_citation/The_Role_of_EGFR_Inhibition_in_the_Treatment_of_Non_Small_Cell_Lung_Cancer_Ray M, Salgia R, Vokes EE 
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Oncologist 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887873/full_citation/Down_staging_of_EGFR_mutation_positive_advanced_lung_carcinoma_with_gefitinib_followed_by_surgical_intervention:_follow_up_of_two_cases_Levchenko EV, Moiseyenko VM, Matsko DE, et al. 
Down-staging of EGFR mutation-positive advanced lung carcinoma with gefitinib followed by surgical intervention: follow-up of two cases. [Journal Article, Research Support, Non-U.S. Gov't]
Onkologie 2009 Nov; 32(11):674-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886911/full_citation/Molecular_mechanism_underlying_the_synergistic_interaction_between_trifluorothymidine_and_the_epidermal_growth_factor_receptor_inhibitor_erlotinib_in_human_colorectal_cancer_cell_lines_Bijnsdorp IV, Kruyt FA, Fukushima M, et al. 
Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines. [JOURNAL ARTICLE]
Cancer Sci 2009 Sep 29.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884861/full_citation/EGFR_Mutations_Detected_in_Plasma_Are_Associated_with_Patient_Outcomes_in_Erlotinib_Plus_Docetaxel_Treated_Non_small_Cell_Lung_Cancer_Mack PC, Holland WS, Burich RA, et al. 
EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Oct 30.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884559/full_citation/Phase_II_Study_of_Erlotinib_in_Patients_With_Locally_Advanced_or_Metastatic_Papillary_Histology_Renal_Cell_Cancer:_SWOG_S0317_Gordon MS, Hussey M, Nagle RB, et al. 
Phase II Study of Erlotinib in Patients With Locally Advanced or Metastatic Papillary Histology Renal Cell Cancer: SWOG S0317. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881544/full_citation/Notch3_cooperates_with_the_EGFR_pathway_to_modulate_apoptosis_through_the_induction_of_bim_Konishi J, Yi F, Chen X, et al. 
Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. [JOURNAL ARTICLE]
Oncogene 2009 Nov 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879012/full_citation/Treatment_of_advanced_non_small_cell_lung_cancer_in_the_elderly_Gridelli C, Maione P, Rossi A, et al. 
Treatment of advanced non-small-cell lung cancer in the elderly. [JOURNAL ARTICLE]
Lung Cancer 2009 Oct 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19878809/full_citation/[Erlotinib_and_nonsmall_cell_lung_cancer_with_brain_metastases:_A_case_study_with_a_complete_and_prolonged_response_over_17_months_]Mairovitz A, Staub E, Le Floch H, et al. 
[Erlotinib and nonsmall cell lung cancer with brain metastases: A case study with a complete and prolonged response over 17 months.] [English Abstract, Journal Article]
Rev Pneumol Clin 2009 Oct; 65(5):318-21.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19865001/full_citation/Simultaneous_Quantification_of_Erlotinib_Gefitinib_and_Imatinib_in_Human_Plasma_by_Liquid_Chromatography_Tandem_Mass_Spectrometry_Chahbouni A, den Burger JC, Vos RM, et al. 
Simultaneous Quantification of Erlotinib, Gefitinib, and Imatinib in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Oct 27.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19859040/full_citation/Targeted_therapies_for_pancreatic_adenocarcinoma_Lowery M, O'Reilly EM 
Targeted therapies for pancreatic adenocarcinoma. [JOURNAL ARTICLE]
Minerva Chir 2009 Oct; 64(5):501-519.
Abstract | Full Citation